At the 2026 ASDS Annual Meeting, Allergan Aesthetics presented nine abstracts including new Phase 4 research on aesthetic treatments for patients using GLP-1 medications for weight loss. The studies focus on patient satisfaction, psychosocial outcomes, and multimodal aesthetic approaches across diverse populations. Additional presentations covered innovations in neurotoxins, body contouring, and skin quality improvements. These findings highlight Allergan's commitment to advancing aesthetic medicine by addressing evolving patient needs with scientific evidence.
Allergan Aesthetics' new research on aesthetic care following medical weight loss provides context for health-sector market activity. For readers following the health sector, here is Pluang's market snapshot as of Nov 03, 2026 20:11 WIB: Out of 150 priced US health stocks, 75 rose and 69 fell. Notable movers include BKD at USD 10.16 with a 1-day change of -2.68% and a typical hold time of 19 days, VRTX at USD 565.98 with a 1-day change of +2.32%, a typical hold time of 123 days, and Pluang order activity showing 25% sell and 75% buy, and TWST at USD 131.82 with a 1-day change of +2.15%, a typical hold time of 27 days, and Pluang order activity showing 18% sell and 82% buy.
The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
